维普中文期刊产品整合服务
27篇 您的检索式:作者名="MAETZLER W"
    题名 作者 年代 出处 被引量
1Impaired trunk stability in individuals at high risk for Parkinson' s disease 显示文摘Maetzler W Mancini M Liepelt-Scarfone I 2012PloS one2012,7,32:1
2Glial cell-line derived neurotrophic factor (GDNF) concentrations in cerebro- spinal fluid and serum of patients with early Alzheimer's dis- ease and normal eontrols显示文摘Straten G Eschweiler GW Maetzler W 2009J Alzheimers Dis2009,18,2:1
3Risk for femoral fractures in Parkinson's disease patients with and without severe functional impairment显示文摘BENZINGER P RAPP K MAETZLER W 2014Plos One2014,9,5:1
4Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-FDG-PET显示文摘Liepeh I Reimold M Maetzler W 2009Mov Disord2009,24,10:1
5Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias显示文摘Maetzler W Berg D Synofzik M Journal of Alzheimer's Disease0,,:1
6Progression of Parkinson's disease in the clinical phase:potential markers显示文摘Maetzler W Liepelt I Berg D 2009Lancet Neurol2009,8,:1
7Progression of Parkinson's disease in the clinical phase:Potential markers显示文摘Maetzler W Liepelt I Berg D 0,,:1
8S100B is increased in Parkin- son'sdisease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-a pathway 显示文摘Sathe K Maetzler W Lang JD 2012Brain2012,135,11:1
9Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration- FDG-PET 显示文摘Liepelt I Reimold M Maetzler W 2009Mov Disord2009,24,10:1
10Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-〔18F〕FDG-PET显示文摘Liepelt I Reimold M Maetzler W 2009Mov Disord2009,24,10:1
1118FFDG-PET for diagnosis of dementia in Parkinson's disease显示文摘Reimold M Liepelt I Maetzler W 2008J Nucl Med2008,491,:1
12GABAB receptor expression and celhdar localization in gerbil hippocampus after transient global ischemia显示文摘Vollenweider F Bendfeldt K Maetzler W 2006Neurosci Lett2006,395,2:1
13Evaluation of progression markers in the premotor phase of parkirtson 's disease: the progression markers in the premotor phase study 显示文摘Liepelt-Scarfone I Gauss K Maetzler W 2013Neuroepidemiology2013,41,34:1
14Impaired Trunk Stability in Individuals at High Risk for Parkinson's Disease显示文摘Maetzler W Mancini M Liepelt Scarfone I 2012PLOS One2012,7,32:1
15Plasma ce-ramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment:a pilot study显示文摘Mielke MM Maetzler W Haughey NJ 0,,09:1
16Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics显示文摘Maetzler W Liepelt I Reimold M 0,,:1
17Cortical PIB bind- ing in Lewy body disease is associated with Alzheimer-like characteristics显示文摘Maetzler W Liepelt I Reimold M 2009Neurobiol Dis2009,34,1:1
18Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson' s disease and associated with cognitive impairment : a pilot study 显示文摘Mielke MM Maetzler W Haughey NJ 2013PLoS One2013,8,73:1
19Neprilysin activity in cerebrospinal fluid is associated with dementia and amy1old-beta42 levels in Lewy body disease显示文摘Maetzler W Stoycheva V Schmid B 0,,03:1
20Progression of Parkinson's disease in the clinical phase: potential markers 显示文摘Maetzler W Liepeh I Berg D 2009Lancet Neurol2009,8,12:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费